Intensive Glucose-Lowering Therapy May Reduce Cardiovascular Disease Events in Hispanics in the Veterans Affairs Diabetes Trial (VADT)

被引：0
|
作者：
Saremi, Aramesh
Bahn, Gideon
Ge, Ling
Moritz, Tom
Schwenke, Dawn C.
Duckworth, William C.
Emanuele, Nicholas
Reda, Domenic
Hayward, Rodney
Reaven, Peter D.
机构：
来源：
DIABETES | 2013年 / 62卷
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
1404-P
引用
收藏
页码：A367 / A367
页数：1
相关论文
共 50 条
  • [1] Intensive Glucose-Lowering Therapy Reduces Cardiovascular Disease Events in Veterans Affairs Diabetes Trial Participants With Lower Calcified Coronary Atherosclerosis
    Reaven, Peter D.
    Moritz, Thomas E.
    Schwenke, Dawn C.
    Anderson, Robert J.
    Criqui, Michael
    Detrano, Robert
    Emanuele, Nicholas
    Kayshap, Moti
    Marks, Jennifer
    Mudaliar, Sunder
    Rao, R. Harsha
    Shah, Jayendra H.
    Goldman, Steven
    Reda, Domenic J.
    McCarren, Madeline
    Abraira, Carlos
    Duckworth, William
    DIABETES, 2009, 58 (11) : 2642 - 2648
  • [2] Intensive Glucose Lowering in the Veterans Affairs Diabetes Trial (VADT) Does Not Lower Inflammatory Factors That Are Associated with Macrovascular Events
    Koska, Juraj
    Saremi, Aramesh
    Moritz, Thomas E.
    Abraira, Carlos
    Duckworth, William
    Reaven, Peter D.
    DIABETES, 2010, 59 : A223 - A224
  • [3] The Effect of Intensive Glucose Lowering on Lipoprotein Particle Profiles and Inflammatory Markers in the Veterans Affairs Diabetes Trial (VADT)
    Koska, Juraj
    Saremi, Aramesh
    Bahn, Gideon
    Yamashita, Shizuya
    Reaven, Peter D.
    DIABETES CARE, 2013, 36 (08) : 2408 - 2414
  • [4] Intensive Glucose Lowering Therapy and Progression of Coronary (CAC) and Abdominal Aortic Artery Calcium (AAC) in the Veterans Affairs Diabetes Trial (VADT)
    Saremi, Aramesh
    Anderson, Robert J.
    Duckworth, William C.
    Abraira, Caflos
    Reaven, Peter D.
    DIABETES, 2010, 59 : A109 - A109
  • [5] Blood Pressure and Cardiovascular Disease Risk in the Veterans Affairs Diabetes Trial (VADT).
    Anderson, R. J.
    Bahn, G.
    Kaufman, D.
    Moritz, T. E.
    Abraira, C.
    Duckworth, W. C.
    ENDOCRINE REVIEWS, 2010, 31 (03)
  • [6] Potential of glucose-lowering drugs to reduce cardiovascular events
    Zarich, Stuart W.
    CURRENT DIABETES REPORTS, 2009, 9 (01) : 87 - 94
  • [7] Potential of glucose-lowering drugs to reduce cardiovascular events
    Stuart W. Zarich
    Current Diabetes Reports, 2009, 9 : 87 - 94
  • [8] The Effect of Intensive Glucose Lowering Therapy Among Major Racial/Ethnic Groups in the Veterans Affairs Diabetes Trial
    Saremi, Aramesh
    Schwenke, Dawn C.
    Bahn, Gideon
    Ge, Ling
    Emanuele, Nicholas
    Reaven, Peter D.
    METABOLISM-CLINICAL AND EXPERIMENTAL, 2015, 64 (02): : 218 - 225
  • [9] Intensive Glycemic Control (INT) and Ocular Outcomes in the Veterans Affairs Diabetes Trial (VADT)
    Azad, Nasrin
    Agrawal, Lily
    Emanuele, Nicholas V.
    Klein, Ronald
    Bahn, Gideon
    Kaufman, Derrick
    Moritz, Thomas
    Reda, Domenic
    Duckworth, William
    Abraira, Carlos
    DIABETES, 2011, 60 : A181 - A181
  • [10] Personalizing Glucose-Lowering Therapy in Patients with Type 2 Diabetes and Cardiovascular Disease
    Inzucchi, Silvio E.
    ENDOCRINOLOGY AND METABOLISM CLINICS OF NORTH AMERICA, 2018, 47 (01) : 137 - +
12345